Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS/LABA Combined With Liqin Zhike Formula in Cough Variant Asthma
NCT07272278Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of Liqin Zhike Formula in cough variant asthma (CVA) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Symptom Recurrence Rate at 12 months. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Liqin Zhike Formula
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on NCT07272278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07272278.